Global Obesity Drugs Market valued at $2.3 billion (2022), is Projected to Witness a Significant Growth Rate of 25% by 2027 BRUSSELS, BELGIUM, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Obesity and overweight are defined as accumulation of excessive or abnormal fat leading to increased risk to health, which can be measured by...

Global Diabetes and Obesity Drugs Market to reach $163.2 Billion by 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment: ResearchMoz Albany, NY, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion,...